IRIDEX Corporation, headquartered in the United States, is a leading innovator in the ophthalmic and aesthetic laser markets. Founded in 1989, the company has established itself as a key player in developing advanced laser systems and delivery devices for the treatment of various eye conditions, including glaucoma and retinal diseases. With a strong focus on precision and efficacy, IRIDEX offers a range of core products, including the popular MicroPulse™ laser technology, which distinguishes itself through its ability to provide targeted treatment with minimal damage to surrounding tissues. The company has achieved significant milestones, including numerous FDA approvals, solidifying its position as a trusted provider in the medical device industry. IRIDEX continues to expand its operational reach, serving healthcare professionals globally while maintaining a commitment to innovation and quality in patient care.
How does IRIDEX Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
IRIDEX Corporation's score of 25 is lower than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
IRIDEX Corporation, headquartered in the US, currently does not report any specific carbon emissions data, as there are no available figures for kg CO2e emissions. Additionally, the company has not established any documented reduction targets or commitments to the Science Based Targets initiative (SBTi). While there is no direct emissions data or climate pledges available, IRIDEX Corporation's commitment to sustainability may be inferred through its participation in industry initiatives, although specific details are not provided. As of now, the company does not inherit emissions data from any parent or related organizations, indicating that its climate strategy is independently developed. In summary, IRIDEX Corporation has yet to disclose its carbon emissions or set formal reduction targets, reflecting a broader context in which many companies are increasingly prioritising climate action and transparency.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
IRIDEX Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
